Market Research Logo

Central America Pharmaceuticals and Healthcare Report Q4 2015

Central America Pharmaceuticals and Healthcare Report Q4 2015

BMI View: Growing demand for pharmaceuticals, compounded by underdeveloped manufacturingcapabilities will ensure commercial opportunities for foreign investors within Central America over thelong term. Multinational drugmakers and medical suppliers will also continue to benefit from favourabletax incentives and growing medicine consumption driven by a booming burden of chronic disease. Sluggisheconomies and political instability will remain problematic, though pharmaceutical and health expenditurewill continue to rise throughout the region.

Headline Expenditure Projections

Pharmaceuticals: USD3.7bn in 2014 to USD3.9bn in 2015; +5.6%. Our forecast has been maintained since Q315.

Healthcare: USD16.8bn in 2014 to USD17.8bn in 2015; +5.8%. Our forecast has been revised upwardssince Q315 due to revised historical data.


BMI Industry View
SWOT
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Central America Pharmaceutical Sales, Historic Data And Forecasts
Guatemala
Table: Guatemala Pharmaceutical Sales Forecasts
Costa Rica
Table: Costa Rica Pharmaceutical Sales Forecasts
El Salvador
Table: El Salvador Pharmaceutical Sales Forecasts
Honduras
Table: Honduras Pharmaceutical Sales Forecasts
Panama
Table: Panama Pharmaceutical Sales Forecasts
Nicaragua
Table: Nicaragua Pharmaceutical Sales Forecasts
Healthcare Market Forecast
Table: Central America Healthcare Expenditure Trends, Historical Data And Forecasts
Guatemala
Table: Guatemala Healthcare Expenditure Forecasts
Costa Rica
Table: Costa Rica Healthcare Expenditure Forecasts
El Salvador
Table: El Salvador Healthcare Expenditure Forecasts
Panama
Table: Panama Healthcare Expenditure Forecasts
Honduras
Table: Honduras Healthcare Expenditure Forecasts
Nicaragua
Table: Nicaragua Healthcare Expenditure Forecasts
Pharmaceutical Trade Forecast
Guatemala
Table: Guatemala Pharmaceutical Trade Data And Forecasts (USDmn)
Costa Rica
Table: Costa Rica Pharmaceutical Trade Data And Forecasts (USDmn)
El Salvador
Table: El Salvador Pharmaceutical Trade Data And Forecasts (USDmn)
Panama
Table: Panama Pharmaceutical Trade Data And Forecasts (USDmn)
Honduras
Table: Honduras Pharmaceutical Trade Data And Forecasts (USDmn)
Nicaragua
Table: Nicaragua Pharmaceutical Trade Data And Forecasts (USDmn)
Industry Risk Reward Indices
Americas Risk/Reward Index - Q4 2015
Central America Risk/Reward Index
Rewards
Risks
Industry Trends And Developments
Epidemiology
Healthcare Sector
Guatemala
Costa Rica
El Salvador
Panama
Honduras
Nicaragua
Clinical Trials
Regulatory Development
Intellectual Property Regime
Costa Rica
El Salvador
Honduras
Nicaragua
Guatemala
Competitive Landscape
Company Profile
Ancalmo Internacional
Donovan Werke
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report